Oculus Research

Hoda Gabriel - President


 Hoda Gabriel is a clinical research and development professional with 28 years of experience directing, designing, planning, and successfully executing early and late phase clinical drug programs within the pharmaceutical industry.  As well as being the President of Oculus Research, Ms. Gabriel is currently the Sr. Director of Clinical Development at T3D Therapeutics. Prior to her current positions, she held director‐level positions with GlaxoSmithKline and Talecris (now Grifols), where she led several international programs and teams to successful NDA/MAA submissions. Additionally, she founded two independent clinical research companies. Ms. Gabriel has experience in the development of multiple therapeutic areas including CNS, Urology, Metabolic, Cardiovascular, Pain, Dermatology and Peripheral Arterial Disease. 

Rosemarie Pladna - Director of Clinical Operations


 Rosemarie Pladna is a Clinical Operations Director for Oculus Research (OR). She  received her BA in Biology and Associate Degree in Nursing at Youngstown  State University. Prior to joining OR, she worked in the Pharmaceutical Industry for over 21 years. Rosemarie’s  career at GlaxoSmithKline included experience as a Senior Clinical  Research Scientist, Clinical Compliance Manager and ultimately an  Account Director for R&D Internal Audit. She was the recipient of a  Platinum Award for her successful work in hosting FDA inspections in  France, Germany and the USA, keeping the company in good standing. She  provides guidance to the OR staff with regard to Good Clinical Practice  in the conduct of human subject research.